Ligation of ICAM-1 on human aortic valve interstitial cells induces the osteogenic response: A critical role of the Notch1-NF-κB pathway in BMP-2 expression

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 11, 2014, Pages 2744-2753

  Wang, Dong ^a,b   Zeng, Qingchun ^a,c   Song, Rui ^a,c   Ao, Lihua ^a   Fullerton, David A ^a   Meng, Xianzhong ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Aortic valve; ICAM 1; Notch1; Pro osteogenic response; Signal transduction

Indexed keywords

EID: 84906070183     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.07.017     Document Type: Article

References (48)

1. Mohler E.R., Gannon F., Reynolds C., Zimmerman R., Keane M.G., Kaplan F.S. Bone formation and inflammation in cardiac valves. Circulation 2001, 103:1522-1528.
2. New S.E., Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ. Res. 2011, 108:1381-1391.
3. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
4. Helske S., Kupari M., Lindstedt K.A., Kovanen P.T. Aortic valve stenosis: an active atheroinflammatory process. Curr. Opin. Lipidol. 2007, 18:483-491.
5. Schoen F.J. Mechanisms of function and disease of natural and replacement heart valves. Annu. Rev. Pathol. 2012, 7:161-183.
6. Osman L., Yacoub M.H., Latif N., Amrani M., Chester A.H. Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation 2006, 114:I547-I552.
7. Meng X., Ao L., Song Y., Babu A., Yang X., Wang M., Weyant M.J., Dinarello C.A., Cleveland J.C., Fullerton D.A. Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. Am. J. Physiol. Cell Physiol. 2008, 294:C29-C35.
8. Yang X., Fullerton D.A., Su X., Ao L., Cleveland J.C., Meng X. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J. Am. Coll. Cardiol. 2009, 53:491-500.
9. Zeng Q., Song R., Ao L., Weyant M.J., Lee J., Xu D., Fullerton D.A., Meng X. Notch1 promotes the pro-osteogenic response of human aortic valve interstitial cells via modulation of ERK1/2 and nuclear factor-kappaB activation. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1580-1590.
10. Yang X., Meng X., Su X., Mauchley D.C., Ao L., Cleveland J.C., Fullerton D.A. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2. J. Thorac. Cardiovasc. Surg. 2009, 138:1008-1015.
11. Kaden J.J., Kilic R., Sarikoc A., Hagl S., Lang S., Hoffmann U., Brueckmann M., Borggrefe M. Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. Int. J. Mol. Med. 2005, 16:869-872.
12. van de Stolpe A., van der Saag P.T. Intercellular adhesion molecule-1. J. Mol. Med. 1996, 74:13-33.
13. Sarantos M.R., Lum A.F., Staunton D.E., Simon S.I. Kinetics of LFA-1 binding to ICAM-1 studied in a cell-free system. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2004, 7:4974-4977.
14. Simon S.I., Green C.E. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu. Rev. Biomed. Eng. 2005, 7:151-185.
15. Green C.E., Schaff U.Y., Sarantos M.R., Lum A.F., Staunton D.E., Simon S.I. Dynamic shifts in LFA-1 affinity regulate neutrophil rolling, arrest, and transmigration on inflamed endothelium. Blood 2006, 107:2101-2111.
16. Muller W.A. Mechanisms of leukocyte transendothelial migration. Annu. Rev. Pathol. 2011, 6:323-344.
17. Li D., Molldrem J.J., Ma Q. LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1/2 signal pathways. J. Biol. Chem. 2009, 284:21001-21010.
18. Rahman A., Fazal F. Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration. Antioxid. Redox Signal. 2009, 11:823-839.
19. Carlos T.M., Harlan J.M. Leukocyte-endothelial cell adhesion molecules. Blood 1994, 84:2068-2101.
20. Lawson C., Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol. Rep. 2009, 61:22-32.
21. Durieu-Trautmann O., Chaverot N., Cazaubon S., Strosberg A.D., Couraud P.O. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J. Biol. Chem. 1994, 269:12536-12540.
22. Sano H., Nakagawa N., Chiba R., Kurasawa K., Saito Y., Iwamoto I. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 1998, 250:694-698.
23. Zeng Q., Jin C., Ao L., Cleveland J.C., Song R., Xu D., Fullerton D.A., Meng X. Cross-talk between the Toll-like receptor 4 and notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves. Circulation 2012, 126:S222-S230.
24. Krunkosky T.M., Jarrett C.L. Selective regulation of MAP kinases and chemokine expression after ligation of ICAM-1 on human airway epithelial cells. Respir. Res. 2006, 7:12.
25. Koyama Y., Tanaka Y., Saito K., Abe M., Nakatsuka K., Morimoto I., Auron P.E., Eto S. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription. J. Immunol. 1996, 157:5097-5103.
26. Lawson C., Ainsworth M., Yacoub M., Rose M. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism. J. Immunol. 1999, 162:2990-2996.
27. Lawson C., Ainsworth M.E., McCormack A.M., Yacoub M., Rose M.L. Effects of cross-linking ICAM-1 on the surface of human vascular smooth muscle cells: induction of VCAM-1 but no proliferation. Cardiovasc. Res. 2001, 50:547-555.
28. Ao L., Zou N., Cleveland J.C.J., Fullerton D.A., Meng X. Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H21-H28.
29. Song R., Zeng Q., Ao L., Yu J.A., Cleveland J.C., Zhao K.S., Fullerton D.A., Meng X. Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2711-2720.
30. Behr B., Tang C., Germann G., Longaker M.T., Quarto N. Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation. Stem Cells 2011, 29:286-296.
31. Cowan C.M., Zhang X., James A.W., Mari Kim T., Sun N., Wu B., Ting K., Soo C. NELL-1 increases pre-osteoblast mineralization using both phosphate transporter Pit1 and Pit2. Biochem. Biophys. Res. Commun. 2012, 422:351-357.
32. Balderman J.A., Lee H.Y., Mahoney C.E., Handy D.E., White K., Annis S., Lebeche D., Hajjar R.J., Loscalzo J., Leopold J.A. Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J. Am. Heart Assoc. 2012, 1:e003905.
33. Fortini M.E. Notch signaling: the core pathway and its posttranslational regulation. Dev. Cell 2009, 16:633-647.
34. Messika-Zeitoun D., Bielak L.F., Peyser P.A., Sheedy P.F., Turner S.T., Nkomo V.T., Breen J.F., Maalouf J., Scott C., Tajik A.J., Enriquez-Sarano M. Aortic valve calcification: determinants and progression in the population. Arterioscler. Thromb. Vasc. Biol. 2007, 27:642-648.
35. Cote N., Mahmut A., Bosse Y., Couture C., Page S., Trahan S., Boulanger M.C., Fournier D., Pibarot P., Mathieu P. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation 2013, 36:573-581.
36. Jaipersad A.S., Lip G.Y., Silverman S., Shantsila E. The role of monocytes in angiogenesis and atherosclerosis. J. Am. Coll. Cardiol. 2014, 63:1-11.
37. Schurpf T., Springer T.A. Regulation of integrin affinity on cell surfaces. EMBO J. 2011, 30:4712-4727.
38. Lu C., Shimaoka M., Ferzly M., Oxvig C., Takagi J., Springer T.A. An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2387-2392.
39. Jun C.D., Shimaoka M., Carman C.V., Takagi J., Springer T.A. Dimerization and the effectiveness of ICAM-1 in mediating LFA-1-dependent adhesion. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6830-6835.
40. Ferreira A.M., Isaacs H., Hayflick J.S., Rogers K.A., Sandig M. The p110delta isoform of PI3K differentially regulates beta1 and beta2 integrin-mediated monocyte adhesion and spreading and modulates diapedesis. Microcirculation 2006, 13:439-456.
41. Monsalve E., Ruiz-Garcia A., Baladron V., Ruiz-Hidalgo M.J., Sanchez-Solana B., Rivero S., Garcia-Ramirez J.J., Rubio A., Laborda J., Diaz-Guerra M.J. Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur. J. Immunol. 2009, 39:2556-2570.
42. Palaga T., Buranaruk C., Rengpipat S., Fauq A.H., Golde T.E., Kaufmann S.H., Osborne B.A. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur. J. Immunol. 2008, 38:174-183.
43. Luna-Zurita L., Prados B., Grego-Bessa J., Luxan G., del Monte G., Benguria A., Adams R.H., Perez-Pomares J.M., de la Pompa J.L. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J. Clin. Invest. 2010, 120:3493-3507.
44. Wang Y., Wu B., Chamberlain A.A., Lui W., Koirala P., Susztak K., Klein D., Taylor V., Zhou B. Endocardial to myocardial notch-wnt-bmp axis regulates early heart valve development. PLoS One 2013, 8:e60244.
45. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
46. Nigam V., Srivastava D. Notch1 represses osteogenic pathways in aortic valve cells. J. Mol. Cell. Cardiol. 2009, 47:828-834.
47. Acharya A., Hans C.P., Koenig S.N., Nichols H.A., Galindo C.L., Garner H.R., Merrill W.H., Hinton R.B., Garg V. Inhibitory role of Notch1 in calcific aortic valve disease. PLoS One 2011, 6:e27743.
48. Nus M., MacGrogan D., Martinez-Poveda B., Benito Y., Casanova J.C., Fernandez-Aviles F., Bermejo J., de la Pompa J.L. Diet-induced aortic valve disease in mice haploinsufficient for the Notch pathway effector RBPJK/CSL. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1580-1588.